ArticleTherapeutics and clinical risk management2013
Eleven years of experience with bisphosphonate plus alfacalcidol treatment in a man with osteogenesis imperfecta type I.
Jun Iwamoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.